Persistent Bone Marrow Minimal Residual Disease is a Poor Prognostic Marker for Neuroblastoma

被引：0
|
作者：
Feng, C. [1 ]
Li, Y. [1 ]
Wu, P. [1 ]
Xiong, X. [1 ]
Peng, X. [1 ]
Weng, W. [1 ]
机构：
[1] Sun Yat Sen Mem Hosp, Pediat Hematol Oncol, Guangzhou, Guangdong, Peoples R China
来源：
PEDIATRIC BLOOD & CANCER | 2019年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO130 SIOP
引用
收藏
页码：S605 / S606
页数：2
相关论文
共 50 条
  • [21] IMMUNOLOGICAL DETECTION AND DEFINITION OF MINIMAL RESIDUAL NEUROBLASTOMA DISEASE IN BONE-MARROW SAMPLES OBTAINED DURING OR AFTER THERAPY
    GUSSETIS, ES
    EBENER, U
    WEHNER, S
    KORNHUBER, B
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (12): : 1745 - 1753
  • [22] Minimal Residual Disease in Bone Marrow of Patients with High Risk Neuroblastoma in 31 Patients from a Single Institution in Argentina
    Cimolai, M.
    Medina, A.
    Mitchell, R.
    Rubio, P.
    Rossi, J.
    Zubizarreta, P.
    Cacciavillano, W.
    Alonso, C.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S225 - S226
  • [23] Evaluation of the expression of neuroblastoma-associated genes for bone marrow (BM) involvement and minimal residual disease (MRD) detection
    Druy, Alexander E.
    Shorikov, Egor V.
    Tsaur, Grigory A.
    Popov, Alexander M.
    Saveliev, Leonid I.
    Fechina, Larisa G.
    CANCER RESEARCH, 2015, 75
  • [24] Wilms tumour gene 1 overexpression in bone marrow as a marker for minimal residual disease in acute myeloid leukaemia
    Haemaelaeinen, Mauri M.
    Kairisto, Veli
    Juvonen, Vesa
    Johansson, Janita
    Auren, Jukka
    Kohonen, Kati
    Remes, Kari
    Salmi, Toivo T.
    Helenius, Hans
    Pelliniemi, Tarja-Terttu
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2008, 80 (03) : 201 - 207
  • [25] Minimal residual marrow disease: Detection and significance of isolated tumour cells in bone marrow
    Iorgulescu, DG
    Kiroff, GK
    ANZ JOURNAL OF SURGERY, 2001, 71 (06) : 365 - 376
  • [26] CELL-KINETICS AND MINIMAL RESIDUAL DISEASE IN BONE-MARROW
    FFRENCH, M
    PATHOLOGIE BIOLOGIE, 1988, 36 (01): : 37 - 39
  • [27] DIAGNOSIS OF MINIMAL RESIDUAL DISEASE IN BONE-MARROW TRANSPLANT PATIENTS
    GEHLY, GB
    CLINICS IN LABORATORY MEDICINE, 1992, 12 (01) : 129 - 151
  • [28] Diagnosis of minimal residual disease in bone marrow and blood in cancer patients
    Kvalheim, G.
    Acta Oncologica, 37 (05): : 455 - 462
  • [29] Molecular assessment of minimal residual disease in PBSC harvests provides prognostic information in neuroblastoma
    Chambon, F.
    Tchirkov, A.
    Pereira, B.
    Rochette, E.
    Demeocq, F.
    Kanold, J.
    PEDIATRIC BLOOD & CANCER, 2013, 60 (09) : E109 - E112
  • [30] WTI gene overexpression as prognostic and minimal residual disease marker of AML patients
    Hämäläinen, M
    Kairisto, V
    Juvonen, V
    Aurén, J
    Pelliniemi, TT
    Rajamäki, A
    CLINICA CHIMICA ACTA, 2005, 355 : S284 - S285
12345